Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Encrypted messengers are having a second wave. Apps like WhatsApp, iMessage and Signal made end-to-end encryption (E2EE) a default expectation. But most still hinge on phone numbers, centralized ...

Major Microsoft Teams Performance Update Rolling Out in January 2026 Your email has been sent Microsoft is splitting the Teams calling stack into a new background process on Windows to cut launch ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...